Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Lucia Brodosi"'
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 39, Iss , Pp 101065- (2024)
Objective: Phenylketonuria (PKU) is a metabolic disorder necessitating lifelong management to prevent severe neurological impairments. This paper synthesises clinical practices from Italian specialist centres to delineate a unified approach for admin
Externí odkaz:
https://doaj.org/article/ac06090c3ff041458e4eadafae1b51d7
Autor:
Lucia Brodosi, Michele Stecchi, Francesca Marchignoli, Elisabetta Lucia, Lucia Magnani, Valeria Guarneri, Maria Letizia Petroni, Giulio Marchesini, Loris Pironi
Publikováno v:
Eating and Weight Disorders, Vol 28, Iss 1, Pp 1-9 (2023)
Abstract Purpose Very few data exist on the association between metabolic dysfunction-associated steatotic liver disease (MASLD) and eating disorders. The study aimed to evaluate the presence of binge eating disorder (BED), in MASLD subjects. Methods
Externí odkaz:
https://doaj.org/article/3f70fef7612e4c08a5e1966f5b176eb0
Autor:
Lucia Brodosi, Michele Stecchi, Dorina Mita, Francesca Marchignoli, Valeria Guarneri, Giulio Agnelli, Valentino Osti, Federica Perazza, Federica Sacilotto, Andrea Pession, Loris Pironi
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-7 (2023)
Abstract Background The Covid pandemic seems to have had several detrimental effects on managing patients affected by inherited metabolic diseases (IMD), although published data about the impact of COVID-19 on patients suffering from IMD are very sca
Externí odkaz:
https://doaj.org/article/2af369cd51594312a7107c85d05cf9bf
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus
Autor:
Marta Nugnes, Maurizio Baldassarre, Danilo Ribichini, Daniele Tedesco, Irene Capelli, Daniele Vetrano, Francesca Marchignoli, Lucia Brodosi, Enrico Pompili, Maria Letizia Petroni, Gaetano La Manna, Giulio Marchesini, Marina Naldi, Manuela Bartolini
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 6, p 3168 (2024)
Diabetic kidney disease (DKD) is a major cause of morbidity and mortality in individuals with type 2 diabetes mellitus (T2DM). The aim of this study was to investigate whether albumin structural alterations correlate with DKD severity and evaluate wh
Externí odkaz:
https://doaj.org/article/92877081d64248bbad0bb6dfde7c2dfe
Publikováno v:
Annals of Hepatology, Vol 28, Iss 1, Pp 100772- (2023)
Externí odkaz:
https://doaj.org/article/773eee6947df499e93d07d03fcdb64d7
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Maturity Onset Diabetes of the Young (MODY) is a monogenic, autosomal, dominant disease that results in beta-cells dysfunction with consequent hyperglycaemia. It represents a rare form of diabetes (1–2% of all the cases). Sulpho
Externí odkaz:
https://doaj.org/article/9ca1f2b9ff104e78bd85d95e82552723
Autor:
Maria Letizia Petroni, Lucia Brodosi, Angelo Armandi, Francesca Marchignoli, Elisabetta Bugianesi, Giulio Marchesini
Publikováno v:
Nutrients, Vol 15, Iss 3, p 792 (2023)
Background: Behavioral programs are needed for prevention and treatment of NAFLD and the effectiveness of a web-based intervention (WBI) is similar to a standard group-based intervention (GBI) on liver disease biomarkers. Objective: We aimed to test
Externí odkaz:
https://doaj.org/article/98639db6c25a48969fde72e08034514e
Autor:
Maria Letizia Petroni, Lucia Brodosi, Francesca Marchignoli, Anna Simona Sasdelli, Paolo Caraceni, Giulio Marchesini, Federico Ravaioli
Publikováno v:
Nutrients, Vol 13, Iss 8, p 2748 (2021)
Unhealthy behaviours, including diet and physical activity, coupled with genetic predisposition, drive type 2 diabetes (T2D) occurrence and severity; the present review aims to summarise the most recent nutritional approaches in T2D, outlining unmet
Externí odkaz:
https://doaj.org/article/d309fcf7cf47499c8aea8ce8eef0e525
Publikováno v:
Annals of Hepatology, Vol 15, Iss 5, Pp 673-681 (2016)
The role of nonalcoholic fatty liver disease, namely nonalcoholic steatohepatitis (NASH), as risk factor for liver- and non-liver-related morbidity and mortality has been extensively reported. In addition to lifestyle changes, capable of removing the
Externí odkaz:
https://doaj.org/article/2045fc57b2604a9d89c5f598e5e37b94
Autor:
Nesrine Gamal, Lucia Brodosi, Cosimo Misciali, Annalisa Patrizi, Gentiana Vukatana, Nazzarena Malavolta, Mauro Bernardi, Pietro Andreone
Publikováno v:
Annals of Hepatology, Vol 13, Iss 2, Pp 293-296 (2014)
For the last decade, the combination therapy of pegylated interferon (Peg-IFN) plus ribavirin (RBV) has been considered as the standard of care treatment for chronic hepatitis C virus (HCV) infection. However, it has been associated with an increased
Externí odkaz:
https://doaj.org/article/cc83bb74763d4deda99d1241715e5cf4